Related Experiment Video
Updated: Jul 7, 2026
09:51
Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes
Published on: March 3, 2020
Stable, micron-scale lipocondensates achieving prolonged circulation without PEGlyated lipids.
Chia-Wei Yeh1, Chelsea A Loh1, Lianne J Trigiani1
1Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA. yw839@cornell.edu.
Biomaterials Science
|July 6, 2026
Summary
Researchers developed novel lipid-containing condensates (LipCons) for drug delivery. These stable, micron-scale assemblies show prolonged circulation and unique lipid organization, offering a versatile platform for sustained systemic delivery.
Area of Science:
- Biochemistry
- Materials Science
- Nanotechnology
Background:
- Biomolecular condensates are crucial for cellular organization and therapeutic delivery.
- Understanding their lipid organization and interfacial behavior is key for developing advanced delivery systems.
Purpose of the Study:
- To investigate lipid-containing condensates (LipCons) for their potential in therapeutic delivery.
- To characterize the unique lipid organization and interfacial properties of LipCons.
Main Methods:
- Formation and characterization of micron-scale lipid-containing condensates (LipCons).
- Assessment of circulation stability and biocompatibility in vivo.
- Analysis of lipid organization and dynamics using Small-angle X-ray Scattering (SAXS) and Fluorescence Recovery After Photobleaching (FRAP).
Main Results:
- LipCons exhibit cell-like dimensions (∼3 µm) and remarkable stability in circulation (∼13-hour half-life), outperforming conventional liposomes.
- LipCons demonstrate unique interfacial lipid organization with reduced mobility and distinct packing.
- The system is PEG-free, offering enhanced stability compared to traditional systems.
Conclusions:
- LipCons represent a novel, stable, and biocompatible platform for sustained systemic delivery.
- Their tunable composition and unique properties make them suitable for advanced therapeutic applications and synthetic biology.
